生命科学资讯
生物技术与制药领域的最新动态
In the clinic for Feb. 11, 2026
Other news to note for Feb. 11, 2026
Madrigal adds siRNA approach to MASH pipeline in $4.4B Ribo deal
NIH ends Xarelto arm of stroke trial due to safety, futility
靶向胆固醇沉积或可治疗淋巴水肿
Targeting cholesterol deposition could treat lymphedema
Moderna因流感疫苗RTF信函股价下跌
Moderna dips on flu vaccine RTF letter
昆山新韵达生物科技合成新型抗体偶联药物
Kunshan Xinyunda Biotechnology synthesizes new ADCs
Aquinnah制药公司获得MAPT聚集抑制剂专利。
Aquinnah Pharmaceuticals patents MAPT aggregation inhibitors
Tempest Therapeutics公布收购CAR T资产计划
Tempest Therapeutics outlines plans for acquired CAR T assets
SUDO-550在多发性硬化症模型中展现强劲疗效
SUDO-550 demonstrates robust efficacy in MS models
Precision Biosciences公司PBGENE-DMD疗法获准进入临床阶段。
Precision Biosciences’ PBGENE-DMD cleared to enter clinic
巴西科学家发现新型HDAC6抑制剂
Brazilian scientists identify new HDAC6 inhibitors
2026年2月10日融资动态
Financings for Feb. 10, 2026
2026年2月10日门诊
In the clinic for Feb. 10, 2026
2026年2月10日其他值得关注新闻
Other news to note for Feb. 10, 2026
2026年2月10日监管动态
Regulatory actions for Feb. 10, 2026
制药公司及高管被控证券欺诈
Pharma company, execs charged with securities fraud
2026年开局：1月融资额达108亿美元。
2026 kicks off with $10.8B January financing haul
Iambic AI与武田达成17亿美元合作协议，提升AI药物研发水平。
Iambic raises the bard in AI, pens $1.7B Takeda deal